Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06329414 · ClinicalTrials.gov registry record

Acceptability and Feasibility of Transcranial Magnetic Stimulation (TMS) for Depression in Multiple Sclerosis

A clinical trial of Multiple Sclerosis and Major Depressive Disorder, sponsored by University of Utah.

Recruiting
Registry status
12
Enrollment target
1
Study location

NCT06329414 is a study of Multiple Sclerosis and Major Depressive Disorder that is actively recruiting participants, run by University of Utah. The registered enrollment target is 12 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06329414, a study of Multiple Sclerosis and Major Depressive Disorder, is actively recruiting participants, sponsored by University of Utah.

RECRUITING
Registry status
12 participants
Enrollment target
1
Study location

Study Summary

The goal of this single-arm, observational pilot study is to learn about the safety, feasibility, preliminary efficacy of TMS for the treatment of depression in people with MS. Participants will receive outpatient TMS treatment over the course of 5-6 weeks. Participants will complete validated questionnaires and exams before, during, and after treatment.

Study Locations (1)

Utah

  • University of Utah Health - Salt Lake City

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2024-01-16
Est. Completion 2026-01

Sponsor

University of Utah

818 total trials

What the Registry Record Tells You About NCT06329414

The ClinicalTrials.gov registry entry for NCT06329414 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (98% lower). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT06329414 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT06329414 about?

NCT06329414 is a clinical study titled "Acceptability and Feasibility of Transcranial Magnetic Stimulation (TMS) for Depression in Multiple Sclerosis". The goal of this single-arm, observational pilot study is to learn about the safety, feasibility, preliminary efficacy of TMS for the treatment of depression in people with MS. Participants will receive outpatient TMS treatment over the course of 5-6 weeks. Participants will complete validated quest...

What is the current status of trial NCT06329414?

This trial is currently recruiting. The enrollment target is 12 participants. The study started on 2024-01-16. Estimated completion is 2026-01.

What conditions does trial NCT06329414 study?

This clinical trial studies the following conditions: Multiple Sclerosis, Major Depressive Disorder, Treatment-Resistant Depression.

Who is sponsoring clinical trial NCT06329414?

This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06329414 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.